14/10/2015
Almac Group Awards Global Tender To Label One
Label One, a specialist label and booklet label manufacturer in Belfast, has been assisted by Invest Northern Ireland and scooped business from the Almac Group.
The company, which employs 48 people in Belfast, received Invest NI support to develop technology that enabled it to win a global tender from Almac's Clinical Services' Business Unit. The contract will see Label One providing booklet labels and leaflets for Almac’s clinical trial products for its sites in Craigavon, the US and Asia.
Michael McGarry, Label One Managing Director, said: "This very significant new business for us came from a decision by Almac to reduce its existing global supply base of booklet label suppliers down to just four. Almac has always been a very important customer, and we were keen to develop the business. It was a contract we had to win and we did our utmost to ensure that we met, indeed surpassed, Almac’s requirements in what is understandably a very exacting and technically challenging industry.
"The booklet labels we provide, for instance, are used as an essential component of the clinical trial and offer guidance to clinicians and patients alike. The construction can involve up to 64 pages in as many of 40 different languages.
"With Invest NI support, we invested around £2 million in state-of-the-art and often bespoke equipment over the past few years so that Label One would be positioned to pitch for more business from Almac and indeed other manufacturers in the Pharmaceutical, Animal Health, and Agrochemical markets."
Image By Press Eye
The company, which employs 48 people in Belfast, received Invest NI support to develop technology that enabled it to win a global tender from Almac's Clinical Services' Business Unit. The contract will see Label One providing booklet labels and leaflets for Almac’s clinical trial products for its sites in Craigavon, the US and Asia.
Michael McGarry, Label One Managing Director, said: "This very significant new business for us came from a decision by Almac to reduce its existing global supply base of booklet label suppliers down to just four. Almac has always been a very important customer, and we were keen to develop the business. It was a contract we had to win and we did our utmost to ensure that we met, indeed surpassed, Almac’s requirements in what is understandably a very exacting and technically challenging industry.
"The booklet labels we provide, for instance, are used as an essential component of the clinical trial and offer guidance to clinicians and patients alike. The construction can involve up to 64 pages in as many of 40 different languages.
"With Invest NI support, we invested around £2 million in state-of-the-art and often bespoke equipment over the past few years so that Label One would be positioned to pitch for more business from Almac and indeed other manufacturers in the Pharmaceutical, Animal Health, and Agrochemical markets."
Image By Press Eye
Related Northern Ireland Business News Stories
Click here for the latest headlines.
06 November 2015
Council Hosts 'Small Business Saturday Bus Tour'
Belfast City Council hosted the 'Small Business Saturday Bus Tour' at City Hall on Thursday, 05 November, which is touring the UK to highlight small business success and encourage people to 'shop local'.
Council Hosts 'Small Business Saturday Bus Tour'
Belfast City Council hosted the 'Small Business Saturday Bus Tour' at City Hall on Thursday, 05 November, which is touring the UK to highlight small business success and encourage people to 'shop local'.
26 November 2013
Almac Group Secures Licensing Deal With Genomic Health
Craigavon based Almac Group has secured a major licensing deal with US company Genomic Health. The California based firm specialises in the development and delivery of cancer diagnostics tests and has paid an initial upfront fee of $9million to secure the rights to further develop and commercialise Almac’s breast cancer test.
Almac Group Secures Licensing Deal With Genomic Health
Craigavon based Almac Group has secured a major licensing deal with US company Genomic Health. The California based firm specialises in the development and delivery of cancer diagnostics tests and has paid an initial upfront fee of $9million to secure the rights to further develop and commercialise Almac’s breast cancer test.
14 August 2014
Almac Group To Invest £54m And Create 348 New Jobs
Enterprise, Trade and Investment Minister Arlene Foster has announced that the Almac Group is investing over £54 million and creating 348 high quality jobs over the next five years.
Almac Group To Invest £54m And Create 348 New Jobs
Enterprise, Trade and Investment Minister Arlene Foster has announced that the Almac Group is investing over £54 million and creating 348 high quality jobs over the next five years.
05 September 2013
Almac Discovery To Invest In Cancer Research Projects
Enterprise Minster Arlene Foster has announced that Almac Discovery is to invest a total of £13million in two research and development projects in collaboration with Queen's University Belfast.
Almac Discovery To Invest In Cancer Research Projects
Enterprise Minster Arlene Foster has announced that Almac Discovery is to invest a total of £13million in two research and development projects in collaboration with Queen's University Belfast.
28 June 2013
Lurgan Firm Exceeds Sales And Export Targets
Lurgan based JH Label Solutions has exceeded all its sales and export targets, securing over £5m in sales in just four years with the support of Invest Northern Ireland.
Lurgan Firm Exceeds Sales And Export Targets
Lurgan based JH Label Solutions has exceeded all its sales and export targets, securing over £5m in sales in just four years with the support of Invest Northern Ireland.